The Report uncovers 9M 2019 business trends of the pharmaceutical market in Azerbaijan, reviews its healthcare system, portrays its epidemiology and demographics. It also depicts pharma regulation features in Azerbaijan including a step-by-step process of the marketing authorization procedure for pharma products. It offers insight into the country’s sociopolitical development since independence, describes recent economic trends, and provides the local pharmaceutical sales forecast for the next three years (2019-2021).

1. Pharmaceutical Country Reports 2019 FY
1
2019 FY
Series
TEASER

2. Pharmaceutical Country Reports 2019 FY
2
Russia
Turkmenistan
Azerbaijan
Kazakhstan
Iran
Georgia
Armenia
Uzbekistan
Turkey
The Report uncovers the 2019 business trends of the pharmaceutical market of
Azerbaijan, overviews its healthcare system, portrays its epidemiology and
demographics.
SUMMARY
Real pages
screenshots
WHY IT IS IMPORTANT FOR DECISION MAKERS IN PHARMA:
▪ You will get a helicopter-view snapshot of the Life Sciences sector of Azerbaijan: its
healthcare system and pharmaceutical market, and epidemiology trends;
▪ It will help you understand the current Azerbaijan’s pharmaceutical market trends;
▪ It clearly shows the structure of the local pharmaceutical market;
▪ You will be able to adjust your planned data to a possible growth curve of a local
pharmaceutical market for a horizon of 2020-2022;
▪ The Report will show you the biggest pharmaceutical companies and brands on the
Azerbaijani market;
▪ You will also understand, how the market is regulated by authorities and see the process
scheme of marketing authorization for a pharmaceutical product or medical device.
TECHNICAL DETAILS
▪ Reporting period: 2013-2019 FY historical data
▪ Forecast period: 2020-2022
▪ Sectors covered: economy, pharmaceutical market, healthcare sector, epidemiology, regulation
▪ Publication date: January 2020
▪ Language: ENG
▪ Additional files: .xlsx, .pptx
▪ All the data in the Report is given in the presentation-ready format – just copy it and paste right into your presentation.
WHO WILL BENEFIT FROM THE REPORT?
▪ PRODUCT & MARKETING MANAGEMENT
▪ BUSINESS DEVELOPMENT
▪ MARKET ACCESS MANAGEMENT
▪ LAUNCH PLANNING
▪ DECISION-MAKING EXECUTIVES
It also depicts pharma regulation features in Azerbaijan including a step-by-step process of marketing
authorization for pharmaceutical products and medical devices. It provides insight of the country’s socio-political
development since independence, describes recent economic trends and gives an economic forecast for the
next 3 years.
CONTENTS
❔ Abbreviations & Definitions
AZERBAIJAN PHARMACEUTICAL COUNTRY REPORT 2019 FY
REPORT DETAILS
Iraq
I. COUNTRY SUMMARY
a. Socio-political situation
b. Economy trends
c. Macroeconomic indicators
II. PHARMA MARKET
a. Supply chain
b. Structure
c. Top-15 companies
d. Top-15 brands
III. PHARMA REGULATION
a. Regulatory environment
b. Marketing authorization
IV. HEALTHCARE
a. Spending
b. Infrastructure
c. Epidemiology

3. Pharmaceutical Country Reports 2019 FY
3
Figure 1 Real GDP and GDP growth rate of Azerbaijan (2013-2018; 2019-2022 (f))
Figure 2 Azerbaijani Manat (AZN) Exchange Rate Dynamics (2013-2019, 2020-2022 (f))
Figure 3 Supply chain of the Azerbaijani pharma market (scheme)
Figure 4 Total Pharmaceutical Market of Azerbaijan, VALUES (2013-2019)
Figure 5 Total Pharmaceutical Market of Azerbaijan, VOLUMES (2013-2019)
Figure 6 Shares of Rx and OTC Medicines on the Total Market (2013-2018)
Figure 7 Weighted Average Cost of a Pack Dynamics (2013-2019)
Figure 8 Shares of Medicines Registered in Azerbaijan by Country of Origin (2019)
Figure 9 Import of Pharmaceuticals to Azerbaijan, VALUES (2013-2019)
Figure 10 Export of Pharmaceuticals from Azerbaijan, VALUES (2013-2019)
Figure 11 Pharma Market Sales Forecast, VALUES (2020-2022)
Figure 12 Pharma Market Sales Forecast, VOLUMES (2020-2022)
Figure 13 Marketing Authorization Procedure in Azerbaijan (scheme)
Figure 14 Annual Healthcare Budget of Azerbaijan Dynamics (2013-2019; 2020(e))
List of FIGURES Used
Table 1 Key Country Indicators (2018)
Table 2 Main macroeconomic indicators (2013-2018, 2019-2022(f))
Table 3
Pharmaceuticals Market Sales (VALUES and VOLUMES) and Weighted Average Cost
of a Pack (2013-2019)
Table 4 Top-15 Companies on the Pharma Market by sales (2018-2019)
Table 5 Top-15 Products on the Pharma Market by sales (2018-2019)
Table 6 Total State Budget and Budget on the Healthcare in Azerbaijan (2013-2019; 2020(e))
Table 7 Healthcare Infrastructure of Azerbaijan by regions (2016-2018, eop)
Table 8 Number of physicians by main specializations in Azerbaijan, persons
Table 9 Population Incidence by Disease Types in Azerbaijan (2016-2018)
Table 10 Main causes of death of the population, ths (2016-2018)
List of TABLES Used
CONTENTS
❔ Abbreviations & Definitions
AZERBAIJAN PHARMACEUTICAL COUNTRY REPORT 2019 FY
REPORT CONTENT
I. COUNTRY SUMMARY
a. Socio-political situation
b. Economy trends
c. Macroeconomic indicators
II. PHARMA MARKET
a. Supply chain
b. Structure
c. Top-15 companies
d. Top-15 brands
III. PHARMA REGULATION
a. Regulatory environment
b. Marketing authorization
IV. HEALTHCARE
a. Spending
b. Infrastructure
c. Epidemiology

4. Pharmaceutical Country Reports 2019 FY
4DISCOVER ALL OTHER REPORTS
REGIONAL COVERAGE
PORTFOLIO
UKRAINE
Pharmaceutical
Country Report
KAZAKHSTAN
Pharmaceutical
Country Report
UZBEKISTAN
Pharmaceutical
Country Report
BELARUS
Pharmaceutical
Country Report
EUR 700.00
RUSSIA
Pharmaceutical
Country Report
AZERBAIJAN
Pharmaceutical
Country Report
GEORGIA
Pharmaceutical
Country Report
ARMENIA
Pharmaceutical
Country Report
More info… More info… More info…
More info… More info… More info…
More info…
More info…
EUR 300.00
EUR 300.00
EUR 500.00
EUR 300.00
EUR 500.00
EUR 300.00
EUR 500.00
EUR 400.00
EUR 700.00
EUR 500.00
EUR 300.00
EUR 500.00
EUR 300.00
EUR 500.00
EUR 300.00
EUR 500.00

5. Pharmaceutical Country Reports 2019 FY
5
Series
COPYRIGHTS & AUTHORS
All rights reserved. No part of this publication may be reproduced in any manner without the prior written permission of UPharma Consulting.
UPharma Consulting LLC is registered in Ukraine, Kyiv, 03039, 30th Holosiivskiy Avenue, building B, office 58, upharma-c.com/en/
Additional information regarding this publication will be furnished upon request.
UPharma Consulting is a professional consulting company, operating in the Life Sciences sector. We analyze pharmaceutical & MedTech
markets and healthcare industries, plan launching new products, recruit pharmaceutical business professionals and support investment
decisions across the CIS and Central Asian region
DISCLAIMER
These publications have been prepared by the research department of
UPharma Consulting (“UPC”).
They are provided to our clients and industry stakeholders for information
purposes only, and UPC makes no express or implied warranties and
expressly disclaims all warranties of merchantability or fitness for a
particular purpose or use concerning any data included in this publication.
UPC will not treat unauthorized recipients of this report as its clients.
Socialmedia
2019 FY